Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
PCSA on Nasdaq
Shares outstanding
55,555,556
Price per share
$0.12
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,780,897
Total reported value
$341,949
% of total 13F portfolios
0%
Share change
+1,408,286
Value change
+$267,535
Number of holders
13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chiliz Group Ltd. 11% $984,093 5,467,181 Chiliz Group Ltd. 05 Aug 2025
CVI Investments, Inc. 9% -9% $959,500 +$101,502 5,000,000 +12% CVI Investments, Inc. 30 Sep 2025
INTRACOASTAL CAPITAL, LLC 10% 0% $595,986 -$22,753 2,907,250 -3.7% Mitchell P. Kopin 30 Jun 2025
ARMISTICE CAPITAL, LLC 5% -50% $555,319 +$433,812 2,644,376 +357% Armistice Capital, LLC 30 Jun 2025
3i, LP 4.9% $386,847 1,681,944 3i, LP 17 Jun 2025

As of 30 Sep 2025, 13 institutional investors reported holding 1,780,897 shares of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA). This represents 3.2% of the company’s total 55,555,556 outstanding shares.

Institutional Holders of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 1,780,897 $341,949 +$267,535 $0.19 13
2025 Q2 372,611 $75,916 +$30,206 $0.20 12
2025 Q1 170,789 $63,197 +$10,380 $0.37 9
2024 Q4 98,935 $87,471 +$44,246 $0.88 8
2024 Q3 48,551 $66,515 +$4,751 $1.37 8
2024 Q2 45,030 $100,974 -$146,754 $2.24 8
2024 Q1 106,331 $251,471 +$251,471 $2.36 9